
Mark C. Gillies
8 Macquarie Street
Sydney, NSW 2000, Australia
Sydney, NSW 2000, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 265 publications
Region-Specific Proteomic Profiles of Extracellular Vesicles (EVs) Derived from Human Macular and Peripheral RPE-Choroid Explants.
Journal: Biomedicines
Published: May 22, 2026
Aflibercept 24-Month Outcomes in Diabetic Macular Edema With and Without Prior Macular Laser Therapy: Data from the Fight Retinal Blindness! Registry.
Journal: Ophthalmology and therapy
Published: May 20, 2026
RWC Update: Gene Therapy in Common Retinal Disorders: Hope, Hype, or Near-term Reality?; 1.4-mm Trophy; Persistent Fetal Vasculature with Tractional Retinal Detachment.
Journal: Ophthalmic surgery, lasers & imaging retina
Published: March 12, 2026
Outcomes in Neovascular Age-Related Macular Degeneration with Visit Gaps under Anti-VEGF Therapy in Daily Practice: Data from the Fight Retinal Blindness! Registry.
Journal: Ophthalmology. Retina
Published: December 12, 2025
Twelve-Month Real-World Outcomes of Faricimab for Treatment-Naive Neovascular AMD in Australia.
Journal: Clinical & experimental ophthalmology
Published: November 04, 2025
Macular Atrophy in the Better-Seeing Eye of Australian Patients Treated for Neovascular Age-Related Macular Degeneration.
Journal: Clinical & experimental ophthalmology
Published: October 21, 2025
Suspending vascular endothelial growth factor inhibitors in eyes with retinal vein occlusion.
Journal: The British journal of ophthalmology
Published: October 04, 2025
Dysregulated Proline Metabolism Contributes to Subretinal Fibrosis in Neovascular AMD: Therapeutic Potential of Prolyl-4-Hydroxylase Inhibition.
Journal: bioRxiv : the preprint server for biology
Published: October 01, 2025
Outcomes of eyes with persistent diabetic macular oedema: The Fight Retinal Blindness! Project.
Journal: The British journal of ophthalmology
Published: September 25, 2025
The Long Journey of Treatment for Wet Macular Degeneration, Is It Worth It?
Journal: Clinical & experimental ophthalmology
Published: September 14, 2025
TALON phase IIIb study: 64 week results of brolucizumab versus aflibercept using treat-and-extend for neovascular age-related macular degeneration.
Journal: Eye (London, England)
Published: September 05, 2025
Vascular endothelial growth factor inhibitors outcomes in good vision eyes with neovascular age-related macular degeneration: Fight Retinal Blindness! SPAIN Report 4.
Journal: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
Published: August 02, 2025
Last Updated: 09/26/2026